PR95711

LONDON, April 28, 2022 /PRNewswire=KYODO JBN/ --

The Danish National Genome Center has awarded Lifebit a four-year contract to

implement Lifebit's Federated Trusted Research Environment software, Lifebit

CloudOS, within Denmark's national supercomputing center.

Lifebit, whose leading technology enables secure analysis over sensitive

datasets for researchers and interconnects such large patient cohorts

worldwide, today announces a long-term partnership with the Danish National

Genome Center (NGC). Lifebit will deploy Lifebit CloudOS to create a Federated

Trusted Research Environment within the Danish NGC's supercomputing cluster to

serve as the scalable and secure data management and analysis platform for

Denmark's national researchers, clinical scientists and international

collaborators.

The Danish NGC, a government agency and authority within the Danish Healthcare

system, was created to implement the Danish Government's National Personalised

Medicine Strategy. The core vision of the NGC is to develop more precise

diagnosis, targeted treatment and strengthen research within the Danish

healthcare system. During the first phase of the strategy, the Danish National

Genome Center and its collaborators will recruit and sequence whole genomes of

60,000 patients diagnosed with cancer, autoimmune disorders and rare diseases

by 2024.

The platform will deliver a next-generation computational infrastructure within

Denmark's on-premise supercomputing center, allowing the NGC to meet its vision

of establishing and operating a state-of-the-art national infrastructure for

personalised medicine while keeping the data at all times in the secure

national infrastructure. Only Lifebit with both its genomic data expertise as

well as its internationally proven ability of managing such complex Government

environments through its patented operating system Lifebit CloudOS was deemed

capable to deliver this project.

The platform will thus enable researchers with secure access, querying and

analysis of this sensitive clinico-genomic data in a fully scalable and

flexible way; also allowing for them to collaborate at a global scale.

Federation will play a crucial role in enabling the future possibility to

collaborate with international partners such as Genomics England, France

Genomique, Genomic Medicine Sweden and other biobanks from around the world.

Virtually connecting these sensitive datasets, enabling joint analysis that is

however performed in situ without moving data, can lead to exponentially higher

research findings. In some cases, it can be observed that increasing the number

of patients in a study by 10x led to ~100x the number of scientific findings

and genomic associations making clear how important real connectivity of these

datasets is.

"Lifebit continues to guide and power the world's largest national and private

precision medicine programmes. We are extremely proud to be delivering this

flagship programme for the nation of Denmark. This Federated Trusted Research

Environment will enable researchers to more effectively collaborate over this

rich dataset at scale and drive international collaboration between other

government initiatives - many of which already leverage Lifebit's federated

technology." Thorben Seeger, Chief Business Development Officer at Lifebit

Other examples of Lifebit's data platform at work include Genomics England [

https://lifebit.ai/blog/genomics-england-launches-next-generation-research-platform-central-to-uk-covid-19-response/

], NIHR Cambridge [

https://www.lifebit.ai/blog/nihr-cambridge-brc-partners-with-lifebit/ ] and the

Hong Kong Genome Institute [

https://lifebit.ai/blog/lifebit-awarded-a-four-year-contract-for-hong-kongs-genome-project/

].

About Lifebit Biotech, Ltd.

Lifebit builds enterprise data platforms for use by organisations with complex

and sensitive biomedical datasets. Lifebit's patented federated technology

securely unlocks access to biomedical data. From providing Trusted Research

Environments for national precision medicine programmes to enabling

pharmaceutical companies to discover new drug targets faster, Lifebit empowers

customers to transform how they leverage sensitive biomedical data.

Photo - https://mma.prnewswire.com/media/1806414/Lifebit_Biotech.jpg

Logo - https://mma.prnewswire.com/media/1752754/lifebit_logo.jpg

Source: Lifebit Biotech